BioSpace News Archive

Neurophth Therapeutics Ltd., a fully integrated genomic medicines company dedicated on seeking to improve lives through the curative potential of gene therapies, announced the closing of over $60 million USD in Series-C financing with a premier syndicate of investors, co-led by CMG-SDIC Capital and Sequoia Capital China.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Trodelvy®.

Gracell Biotechnologies Inc. today announced that members of its senior management team, including its Board and Chief Executive Officer Dr. William (Wei) Cao, Chief Financial Officer Dr. Yili Kevin Xie and Chief Medical Officer Dr. Martina A. Sersch, have informed the Company of their intention to use their personal funds to purchase the Company’s American depositary shares (“ADSs”) on the open market for an aggregate amount up to a maximum of $2 million within the next three months.

Sprout Health Solutions presented new insights on the use of social media listening (SML) for understanding patient experience in chronic disease at Virtual ISPOR EU, the leading European conference for Health Economics and Outcomes Research (HEOR).

Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it acquired Solaris Biotechnology Srl.

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it will participate in Evercore ISI’s 4th Annual HealthCONx Virtual Conference.

Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the publication of results underscoring the importance of adverse pathology as a reliable and critical endpoint for risk-assessment in clinically low-risk prostate cancer patients.

Mitsubishi Tanabe Pharma Canada, Inc., a subsidiary of Mitsubishi Tanabe Pharma America, Inc., announced that RADICAVA®, an infusion treatment for amyotrophic lateral sclerosis, is now reimbursed through Prince Edward Island Pharmacare under Special Authorization.

Merck today announced that Health Canada has granted conditional approval for KEYTRUDA.

BioInvent International that it will host a key opinion leader (KOL) webinar Friday, December 17 at 1 pm ET (7 pm CET).